Cargando…
Allometrically scaling tissue forces drive pathological foreign-body responses to implants via Rac2-activated myeloid cells
Small animals do not replicate the severity of the human foreign-body response (FBR) to implants. Here we show that the FBR can be driven by forces generated at the implant surface that, owing to allometric scaling, increase exponentially with body size. We found that the human FBR is mediated by im...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10651488/ https://www.ncbi.nlm.nih.gov/pubmed/37749310 http://dx.doi.org/10.1038/s41551-023-01091-5 |
_version_ | 1785136008667332608 |
---|---|
author | Padmanabhan, Jagannath Chen, Kellen Sivaraj, Dharshan Henn, Dominic Kuehlmann, Britta A. Kussie, Hudson C. Zhao, Eric T. Kahn, Anum Bonham, Clark A. Dohi, Teruyuki Beck, Thomas C. Trotsyuk, Artem A. Stern-Buchbinder, Zachary A. Than, Peter A. Hosseini, Hadi S. Barrera, Janos A. Magbual, Noah J. Leeolou, Melissa C. Fischer, Katharina S. Tigchelaar, Seth S. Lin, John Q. Perrault, David P. Borrelli, Mimi R. Kwon, Sun Hyung Maan, Zeshaan N. Dunn, James C. Y. Nazerali, Rahim Januszyk, Michael Prantl, Lukas Gurtner, Geoffrey C. |
author_facet | Padmanabhan, Jagannath Chen, Kellen Sivaraj, Dharshan Henn, Dominic Kuehlmann, Britta A. Kussie, Hudson C. Zhao, Eric T. Kahn, Anum Bonham, Clark A. Dohi, Teruyuki Beck, Thomas C. Trotsyuk, Artem A. Stern-Buchbinder, Zachary A. Than, Peter A. Hosseini, Hadi S. Barrera, Janos A. Magbual, Noah J. Leeolou, Melissa C. Fischer, Katharina S. Tigchelaar, Seth S. Lin, John Q. Perrault, David P. Borrelli, Mimi R. Kwon, Sun Hyung Maan, Zeshaan N. Dunn, James C. Y. Nazerali, Rahim Januszyk, Michael Prantl, Lukas Gurtner, Geoffrey C. |
author_sort | Padmanabhan, Jagannath |
collection | PubMed |
description | Small animals do not replicate the severity of the human foreign-body response (FBR) to implants. Here we show that the FBR can be driven by forces generated at the implant surface that, owing to allometric scaling, increase exponentially with body size. We found that the human FBR is mediated by immune-cell-specific RAC2 mechanotransduction signalling, independently of the chemistry and mechanical properties of the implant, and that a pathological FBR that is human-like at the molecular, cellular and tissue levels can be induced in mice via the application of human-tissue-scale forces through a vibrating silicone implant. FBRs to such elevated extrinsic forces in the mice were also mediated by the activation of Rac2 signalling in a subpopulation of mechanoresponsive myeloid cells, which could be substantially reduced via the pharmacological or genetic inhibition of Rac2. Our findings provide an explanation for the stark differences in FBRs observed in small animals and humans, and have implications for the design and safety of implantable devices. |
format | Online Article Text |
id | pubmed-10651488 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-106514882023-09-25 Allometrically scaling tissue forces drive pathological foreign-body responses to implants via Rac2-activated myeloid cells Padmanabhan, Jagannath Chen, Kellen Sivaraj, Dharshan Henn, Dominic Kuehlmann, Britta A. Kussie, Hudson C. Zhao, Eric T. Kahn, Anum Bonham, Clark A. Dohi, Teruyuki Beck, Thomas C. Trotsyuk, Artem A. Stern-Buchbinder, Zachary A. Than, Peter A. Hosseini, Hadi S. Barrera, Janos A. Magbual, Noah J. Leeolou, Melissa C. Fischer, Katharina S. Tigchelaar, Seth S. Lin, John Q. Perrault, David P. Borrelli, Mimi R. Kwon, Sun Hyung Maan, Zeshaan N. Dunn, James C. Y. Nazerali, Rahim Januszyk, Michael Prantl, Lukas Gurtner, Geoffrey C. Nat Biomed Eng Article Small animals do not replicate the severity of the human foreign-body response (FBR) to implants. Here we show that the FBR can be driven by forces generated at the implant surface that, owing to allometric scaling, increase exponentially with body size. We found that the human FBR is mediated by immune-cell-specific RAC2 mechanotransduction signalling, independently of the chemistry and mechanical properties of the implant, and that a pathological FBR that is human-like at the molecular, cellular and tissue levels can be induced in mice via the application of human-tissue-scale forces through a vibrating silicone implant. FBRs to such elevated extrinsic forces in the mice were also mediated by the activation of Rac2 signalling in a subpopulation of mechanoresponsive myeloid cells, which could be substantially reduced via the pharmacological or genetic inhibition of Rac2. Our findings provide an explanation for the stark differences in FBRs observed in small animals and humans, and have implications for the design and safety of implantable devices. Nature Publishing Group UK 2023-09-25 2023 /pmc/articles/PMC10651488/ /pubmed/37749310 http://dx.doi.org/10.1038/s41551-023-01091-5 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Padmanabhan, Jagannath Chen, Kellen Sivaraj, Dharshan Henn, Dominic Kuehlmann, Britta A. Kussie, Hudson C. Zhao, Eric T. Kahn, Anum Bonham, Clark A. Dohi, Teruyuki Beck, Thomas C. Trotsyuk, Artem A. Stern-Buchbinder, Zachary A. Than, Peter A. Hosseini, Hadi S. Barrera, Janos A. Magbual, Noah J. Leeolou, Melissa C. Fischer, Katharina S. Tigchelaar, Seth S. Lin, John Q. Perrault, David P. Borrelli, Mimi R. Kwon, Sun Hyung Maan, Zeshaan N. Dunn, James C. Y. Nazerali, Rahim Januszyk, Michael Prantl, Lukas Gurtner, Geoffrey C. Allometrically scaling tissue forces drive pathological foreign-body responses to implants via Rac2-activated myeloid cells |
title | Allometrically scaling tissue forces drive pathological foreign-body responses to implants via Rac2-activated myeloid cells |
title_full | Allometrically scaling tissue forces drive pathological foreign-body responses to implants via Rac2-activated myeloid cells |
title_fullStr | Allometrically scaling tissue forces drive pathological foreign-body responses to implants via Rac2-activated myeloid cells |
title_full_unstemmed | Allometrically scaling tissue forces drive pathological foreign-body responses to implants via Rac2-activated myeloid cells |
title_short | Allometrically scaling tissue forces drive pathological foreign-body responses to implants via Rac2-activated myeloid cells |
title_sort | allometrically scaling tissue forces drive pathological foreign-body responses to implants via rac2-activated myeloid cells |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10651488/ https://www.ncbi.nlm.nih.gov/pubmed/37749310 http://dx.doi.org/10.1038/s41551-023-01091-5 |
work_keys_str_mv | AT padmanabhanjagannath allometricallyscalingtissueforcesdrivepathologicalforeignbodyresponsestoimplantsviarac2activatedmyeloidcells AT chenkellen allometricallyscalingtissueforcesdrivepathologicalforeignbodyresponsestoimplantsviarac2activatedmyeloidcells AT sivarajdharshan allometricallyscalingtissueforcesdrivepathologicalforeignbodyresponsestoimplantsviarac2activatedmyeloidcells AT henndominic allometricallyscalingtissueforcesdrivepathologicalforeignbodyresponsestoimplantsviarac2activatedmyeloidcells AT kuehlmannbrittaa allometricallyscalingtissueforcesdrivepathologicalforeignbodyresponsestoimplantsviarac2activatedmyeloidcells AT kussiehudsonc allometricallyscalingtissueforcesdrivepathologicalforeignbodyresponsestoimplantsviarac2activatedmyeloidcells AT zhaoerict allometricallyscalingtissueforcesdrivepathologicalforeignbodyresponsestoimplantsviarac2activatedmyeloidcells AT kahnanum allometricallyscalingtissueforcesdrivepathologicalforeignbodyresponsestoimplantsviarac2activatedmyeloidcells AT bonhamclarka allometricallyscalingtissueforcesdrivepathologicalforeignbodyresponsestoimplantsviarac2activatedmyeloidcells AT dohiteruyuki allometricallyscalingtissueforcesdrivepathologicalforeignbodyresponsestoimplantsviarac2activatedmyeloidcells AT beckthomasc allometricallyscalingtissueforcesdrivepathologicalforeignbodyresponsestoimplantsviarac2activatedmyeloidcells AT trotsyukartema allometricallyscalingtissueforcesdrivepathologicalforeignbodyresponsestoimplantsviarac2activatedmyeloidcells AT sternbuchbinderzacharya allometricallyscalingtissueforcesdrivepathologicalforeignbodyresponsestoimplantsviarac2activatedmyeloidcells AT thanpetera allometricallyscalingtissueforcesdrivepathologicalforeignbodyresponsestoimplantsviarac2activatedmyeloidcells AT hosseinihadis allometricallyscalingtissueforcesdrivepathologicalforeignbodyresponsestoimplantsviarac2activatedmyeloidcells AT barrerajanosa allometricallyscalingtissueforcesdrivepathologicalforeignbodyresponsestoimplantsviarac2activatedmyeloidcells AT magbualnoahj allometricallyscalingtissueforcesdrivepathologicalforeignbodyresponsestoimplantsviarac2activatedmyeloidcells AT leeoloumelissac allometricallyscalingtissueforcesdrivepathologicalforeignbodyresponsestoimplantsviarac2activatedmyeloidcells AT fischerkatharinas allometricallyscalingtissueforcesdrivepathologicalforeignbodyresponsestoimplantsviarac2activatedmyeloidcells AT tigchelaarseths allometricallyscalingtissueforcesdrivepathologicalforeignbodyresponsestoimplantsviarac2activatedmyeloidcells AT linjohnq allometricallyscalingtissueforcesdrivepathologicalforeignbodyresponsestoimplantsviarac2activatedmyeloidcells AT perraultdavidp allometricallyscalingtissueforcesdrivepathologicalforeignbodyresponsestoimplantsviarac2activatedmyeloidcells AT borrellimimir allometricallyscalingtissueforcesdrivepathologicalforeignbodyresponsestoimplantsviarac2activatedmyeloidcells AT kwonsunhyung allometricallyscalingtissueforcesdrivepathologicalforeignbodyresponsestoimplantsviarac2activatedmyeloidcells AT maanzeshaann allometricallyscalingtissueforcesdrivepathologicalforeignbodyresponsestoimplantsviarac2activatedmyeloidcells AT dunnjamescy allometricallyscalingtissueforcesdrivepathologicalforeignbodyresponsestoimplantsviarac2activatedmyeloidcells AT nazeralirahim allometricallyscalingtissueforcesdrivepathologicalforeignbodyresponsestoimplantsviarac2activatedmyeloidcells AT januszykmichael allometricallyscalingtissueforcesdrivepathologicalforeignbodyresponsestoimplantsviarac2activatedmyeloidcells AT prantllukas allometricallyscalingtissueforcesdrivepathologicalforeignbodyresponsestoimplantsviarac2activatedmyeloidcells AT gurtnergeoffreyc allometricallyscalingtissueforcesdrivepathologicalforeignbodyresponsestoimplantsviarac2activatedmyeloidcells |